Finance

Lists
RMTI:NASDAQ
Rockwell Medical Ord Shs
$7.41
-5.30%
(-0.41) 1D
Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMTI...
Open
$7.70
High
$7.70
Low
$7.36
Mkt. cap
29.41M
Avg. vol.
36.09K
Volume
20.82K
52-wk high
$21.00
52-wk low
$4.88
EPS
-$1.51
Beta
1.60
Shares outstanding
3.95M
No. of employees
157
Open
$7.70
High
$7.70
Low
$7.36
Mkt. cap
29.41M
Avg. vol.
36.09K
Volume
20.82K
52-wk high
$21.00
52-wk low
$4.88
EPS
-$1.51
Beta
1.60
Shares outstanding
3.95M
No. of employees
157
News stories
From web sources and news partners
Profile
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease. The company's primary customers are dialysis providers. Wikipedia
About Rockwell Medical Ord Shs
CEO-
Employees157
Founded1996
HeadquartersWixom, Michigan, United States
SectorMedical device
Websiterockwellmed.com
Analyst ratings
Based on 1 analyst giving stock ratings to RMTI in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for RMTI in the last 3 months
Highest
Current $7.41
$20.00 (+169.91%)
Average
$20.00 (+169.91%)
Lowest
$20.00 (+169.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+169.9%
07/09/2026
Anthony Vendetti
Maxim Group
Buy
Maintained
$40.00
+439.8%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.93M
18.35M
17.34M
17.78M
Cost of goods sold
13.66M
14.47M
14.44M
14.54M
Cost of revenue
13.66M
14.47M
14.44M
14.54M
Research and development expenses
-
-
-
40.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.86M
4.28M
4.38M
4.26M
Operating expense
3.86M
4.28M
4.38M
4.30M
Total operating expenses
17.51M
18.74M
18.82M
18.84M
Operating income
-1.58M
-398.00K
-1.48M
-1.06M
Other non operating income
-
-
-
-
EBT including unusual items
-1.75M
-554.00K
-1.60M
-1.17M
EBT excluding unusual items
-1.81M
-640.00K
-1.72M
-1.30M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.75M
-554.00K
-1.60M
-1.17M
Net profit margin
-11.01%
-3.02%
-9.26%
-6.59%
Earnings per share
-
-
-
-
Interest and investment income
55.00K
44.00K
37.00K
40.00K
Interest expense
-285.00K
-286.00K
-282.00K
-281.00K
Net interest expenses
-230.00K
-242.00K
-245.00K
-241.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.04M
148.00K
-969.00K
-550.00K
Gain or loss from assets sale
-1.00K
1.00K
178.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps